India: Vajikarana, Generics & Dhat Syndrome
Ayurvedic virilization tradition, Unani Hakim clinics, the generic-sildenafil engine, and a culture-bound semen-loss anxiety
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Mixed: India is a global generic-sildenafil manufacturer; Ayurvedic/Unani sexual tonics are regulated under AYUSH, not as drugs
Reference only. Not medical advice.
What can go wrong
Dhat-related distress can cause real morbidity (anxiety, depression, ED, treatment-seeking from unqualified 'sexologists') and is exploited by quacks selling tonics for 'semen loss'. Some Ayurvedic/Unani products have been found contaminated with heavy metals (lead, mercury, arsenic) or adulterated with undeclared sildenafil. The same Indian generic industry that provides legitimate affordable PDE5 drugs also supplies the global grey/black market.
This is something to take to a clinician. The Atlas can tell you what is known about india: vajikarana, generics & dhat syndrome in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
India combines three distinct systems of male sexual medicine. Classical Ayurveda has an entire branch, vajikarana ('making one like a horse', the aphrodisiac/virilization rasayana), covering tonics, diet, and aphrodisiacs to enhance potency and progeny. Unani medicine, delivered by Hakims, offers a parallel humoral tradition. Overlaid on both is India's role as the world's generic-drug factory: Indian manufacturers produce most of the planet's generic sildenafil and tadalafil. Culturally, dhat syndrome, distress and somatic symptoms attributed to perceived semen loss in urine, is a recognized South Asian culture-bound condition listed in psychiatric cross-cultural glossaries.
The world's generics pharmacy, layered over an ancient virilization science and a famous semen-loss syndrome.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Vajikarana operates on Ayurvedic dosha/dhatu logic, treating shukra dhatu (reproductive tissue) as the end product of metabolism to be nourished by aphrodisiac foods and herbs. Several vajikarana herbs (ashwagandha, Mucuna pruriens) have plausible bioactivity in preclinical and limited human studies, but classical claims are not RCT-grade. Dhat syndrome has no organic basis; it is understood as a cultural idiom of distress in which normal physiological fluid loss is reframed as depletion of vital essence, often co-occurring with anxiety/depression.
What people get wrong
Often saidLosing semen drains vital strength and must be 'restored' with tonics
ActuallyDhat syndrome reflects a cultural belief, not a physiological deficiency; routine seminal/urinary fluid loss does not deplete health. Tonics sold for it lack disease-treating evidence.
Often said'Ayurvedic' sexual tonics are inherently safe and natural
ActuallySome marketed products have shown heavy-metal contamination or hidden sildenafil; AYUSH regulation differs from drug-grade pharmacovigilance.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Vajikarana appears in the Charaka and Sushruta Samhitas (roughly 1st millennium BCE-CE), framing virilization as both a medical and reproductive duty. Dhat syndrome was first described in the modern literature by N. N. Wig in 1960 as a clinical entity of young men complaining of passing 'dhat' (semen) and consequent weakness; it remains a textbook example of a culture-bound syndrome and is referenced in DSM-5 and ICD-11 cross-cultural discussions. India's generic-drug ascendancy followed its 1970 Patents Act (process-patent regime), which let firms reverse-engineer molecules and made the country the 'pharmacy of the developing world'.
- ~1st millennium BCE-CECharaka/Sushruta Samhitas codify vajikarana
- 1960N. N. Wig describes dhat syndrome in the modern literature
- 1970Indian Patents Act enables generic-manufacturing boom
- Post-1998Indian firms become a leading global source of generic sildenafil after patents lapse abroad
- 2014AYUSH established as a dedicated ministry, formalizing Ayurveda/Unani regulation
What we do not know
- How can dhat-related distress be treated respectfully without reinforcing the depletion belief?
- What share of Indian-made generics flows into unregulated global online sales?
- Do specific vajikarana herbs (ashwagandha, Mucuna) have replicable human sexual-health effects?
Legal status
PDE5 generics are extremely cheap and widely available (often sold OTC in practice despite prescription rules). Parallel access runs through Ayurvedic/Unani practitioners, branded tonic brands, and a large informal 'sexologist' clinic sector that frequently targets dhat-anxiety and 'weakness' complaints.
Status current as of July 2026. Regulatory positions change, sometimes quickly.
At a glance
- Ayurvedic branch
- Vajikarana (one of Ashtanga Ayurveda's eight branches)
- Parallel system
- Unani medicine (Hakim practitioners), regulated under AYUSH
- Generic role
- Major global source of generic sildenafil/tadalafil APIs and tablets
- Culture-bound syndrome
- Dhat syndrome (semen-loss anxiety)
- Classic herb
- Mucuna pruriens, Withania (ashwagandha), Asparagus racemosus (shatavari)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about India: Vajikarana, Generics & Dhat Syndrome. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.